Publications

 

Bacteriophage

Jaillard M, van Belkum A, Cady KC, Creely D, Shortridge D, Blanc B, Barbu EM, Dunne WM Jr, Zambardi G, Enright M, Mugnier N, Le Priol C, Schicklin S, Guigon G, Veyrieras JB. Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa. Int J Antimicrob Agents. 2017
Aug;50(2):210-218. VIEW

Barbu EM, Cady KC, Hubby B. Phage Therapy in the Era of Synthetic Biology. Cold Spring Harb Perspect Biol. 2016 Oct 3;8(10). VIEW

van Belkum A, Soriaga LB, LaFave MC, Akella S, Veyrieras JB, Barbu EM, Shortridge D, Blanc B, Hannum G, Zambardi G, Miller K, Enright MC, Mugnier N, Brami D, Schicklin S, Felderman M, Schwartz AS, Richardson TH, Peterson TC, Hubby B, Cady KC. Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa. MBio. 2015 Nov 24;6(6):e01796-15. VIEW

 

STAMPs

Enhanced understanding of the microbiome is helping medicine. The Economist. November 9, 2017. VIEW

Frias-Lopez, J. Targeting specific bacteria in the oral microbiome. Trends in Microbiology. 24 July 2015. VIEW

Guo L, McLeanb JS, Yang Y, Eckert R, Kaplan CW, Kyme P, Sheikh O, Varnum B, Lux R, Shi W, He X. A precision guided antimicrobial peptide as a targeted modulator of human microbial ecology. The Proceedings of the National Academy of Sciences(PNAS) of the United States of America 2015 ; published ahead of print June 1, 2015, doi:10.1073/pnas.1506207112VIEW

Eckert R, Sullivan R, Shi W. Targeted antimicrobial treatment to re-establish a healthy microbial flora for long-term protection. Advances in Dental Research, 2012 September; 24(2):94-97. VIEW

Sullivan R, Santarpia P, Lavender S, Gittins E, Liu Z, Anderson MH, He J, Shi W, Eckert R. Clinical efficacy of a specifically targeted antimicrobial peptide mouth rinse: Targeted elimination of Streptococcus mutans and prevention of demineralization. Caries Research 2011;45(5):415-428. VIEW

Kaplan CW, Sim JH, Shah KR, Kolesnikova-Kaplan A, Shi W, Eckert R. Selective membrane disruption: Mode of action of C16G2, a specifically targeted antimicrobial peptide. Antimicrob Agents Chemother, 2011 Jul; 55:3446-3452VIEW

Li L, Guo LH, Lux R, Eckert R, Yarbrough DK, He J, Anderson M, Shi W. Targeted antimicrobial therapy against Streptococcus mutans establishes protective non-cariogenic oral biofilms and reduces subsequent infection. International Journal of Oral Science, 2010 April;1(2):66-73. VIEW

Eckert R, He J, Yarbrough DK, Qi F, Anderson MH, Shi W. Targeted killing of Streptococcus mutans by a pheromone-guided “smart” antimicrobial peptide. Antimicrob Agents Chemother, 2006 Nov;50(11):3651-7. VIEW